skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Abstract of Title
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Total Assignments: 3
Patent #:
Issue Dt:
04/17/2001
Application #:
09286098
Filing Dt:
04/02/1999
Inventors:
GEORGE WEINER, ARTHUR M. KRIEG
Title:
METHODS AND PRODUCTS FOR STIMULATING THE IMMUNE SYSTEM USING IMMUNOTHERAPEUTIC OLIGONUCLEOTIDES AND CYTOKINES
Assignment: 1
Reel/Frame:
010401/0001Recorded: 11/18/1999Pages: 5
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
Exec Dt:
10/25/1999
Exec Dt:
11/11/1999
Assignee:
OAKDALE RESEARCH CAMPUT
214 TECHNOLOGY INNOVATION CENTER
IOWA CITY, IOWA 52242
Correspondent:
WOLF, GREENFIELD & SACKS, P.C.
HELEN C. LOCKHART, ESQ.
FEDERAL RESERVE PLAZA
600 ATLANTIC AVENUE
BOSTON, MA 02210
Assignment: 2
Reel/Frame:
021669/0865Recorded: 10/13/2008Pages: 2
Conveyance:
CONFIRMATORY LICENSE (SEE DOCUMENT FOR DETAILS).
Assignor:
Exec Dt:
03/01/2002
Assignee:
NIH DIVISION OF EXTRAMURAL INVENTIONS AND TECHNOLOGY RESOURCES (DEITR)
6705 ROCKLEDGE DRIVE, SUITE 310, MSC 7980
BETHESDA, MARYLAND 20892-7980
Correspondent:
DIRECTOR, DEITR
NIH, 6705 ROCKLEDGE DRIVE, SUITE 310
MSC 7980
BETHESDA, MD 20892-7980
Assignment: 3
Reel/Frame:
017353/0372Recorded: 12/20/2005Pages: 11
Conveyance:
CONFIRMATION OF EXCLUSIVE PATENT LICENSE
Assignors:
Exec Dt:
05/06/2005
Exec Dt:
05/06/2005
Exec Dt:
05/06/2005
Assignee:
235 EAST 42ND STREET
NEW YORK, NEW YORK 10017
Correspondent:
LINDA LIBRETTO
C/O PFIZER INC.
235 EAST 42ND STREET
MAIL STOP 235/26/4
NEW YORK, NY 10017

Search Results as of: 06/19/2024 11:23 AM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT